Cargando…
Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial
INTRODUCTION: Therapeutic schedules for treating neonatal seizures remain elusive. First-line treatment with phenobarbital is widely supported but without strong scientific evidence. Levetiracetam (LEV) is an emerging and promising antiepileptic drug (AED). The aim of this phase II trial is to deter...
Autores principales: | Favrais, Geraldine, Ursino, Moreno, Mouchel, Catherine, Boivin, Estelle, Jullien, Vincent, Zohar, Sarah, Saliba, Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347888/ https://www.ncbi.nlm.nih.gov/pubmed/30679288 http://dx.doi.org/10.1136/bmjopen-2018-022739 |
Ejemplares similares
-
Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic–ischaemic encephalopathy
por: Pakvasa, Mitali A, et al.
Publicado: (2017) -
Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial
por: Matsuyama, Nao, et al.
Publicado: (2022) -
Alteration of the Oligodendrocyte Lineage Varies According to the Systemic Inflammatory Stimulus in Animal Models That Mimic the Encephalopathy of Prematurity
por: Favrais, Geraldine, et al.
Publicado: (2022) -
Evolution of early cerebral NIRS in hypoxic ischaemic encephalopathy
por: Garvey, Aisling A., et al.
Publicado: (2022) -
The Metabolomic Profile of Umbilical Cord Blood in Neonatal Hypoxic Ischaemic Encephalopathy
por: Walsh, Brian H., et al.
Publicado: (2012)